Drivers of Radioresistance in Prostate Cancer

Prostate cancer (PCa) is the second most commonly diagnosed cancer worldwide. Radiotherapy remains one of the first-line treatments in localised disease and may be used as monotherapy or in combination with other treatments such as androgen deprivation therapy or radical prostatectomy. Despite advan...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Liam, Bernaitis, Nijole, Christie, David, Chess-Williams, Russ, Sellers, Donna, McDermott, Catherine, Dare, Wendy, Anoopkumar-Dukie, Shailendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573022/
https://www.ncbi.nlm.nih.gov/pubmed/36233505
http://dx.doi.org/10.3390/jcm11195637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573022/
https://www.ncbi.nlm.nih.gov/pubmed/36233505
http://dx.doi.org/10.3390/jcm11195637

Ejemplares similares